Clinical trial Recruiting at 1 site Observational Ages 35 to 55 Women only

Wearable device to track perimenopausal and menopausal symptoms

Official title: An Observational Virtual Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

Run by IdentifyHer Limited · NCT07022925 · Data updated 2026-11-12

This project will test whether a wearable sensor can accurately detect hot flashes, night sweats, sleep problems, and anxiety-related signals in women aged 35–55 going through perimenopause by comparing device readings with daily reports in an app.

Quick facts

Study typeObservational
Ages35 Years to 55 Years
SexWomen only
Enrollment110 (estimated)
SponsorIdentifyHer Limited
Industry-sponsored
Locations1 site (London, Ontario)
StatusRecruiting
StartedJuly 4, 2025
Main results expectedOctober 2025
Study endsOctober 2025
Registry record updatedSeptember 18, 2025
Trial IDNCT07022925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 35–55 who self-identify as perimenopausal, experience hot flushes or night sweats, are generally healthy, agree to use contraception if of child-bearing potential, and can comply with wearing the device and completing daily app entries are ideal candidates.

Probably not a fit

Women who are not experiencing vasomotor symptoms, are clearly postmenopausal, are pregnant or planning pregnancy, have allergies or sensitivities to wearable materials, or have unstable medical conditions are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study asks perimenopausal women to wear IdentifyHer’s non-invasive wearable sensor and complete a daily electronic diary plus questionnaires on stress, anxiety, and sleep. The device’s algorithm-generated events will be compared to participant self-reports in the app to measure agreement and accuracy. Outcomes will include metrics such as sensitivity, specificity, and overall concordance for vasomotor symptoms, sleep disturbances, and anxiety-related patterns. The study is run with KGK Science Inc. in London, Ontario and enrolls generally healthy women who report hot flashes or night sweats.

Why it matters

Potential benefit: If successful, the wearable could provide objective, continuous symptom tracking to help women and clinicians monitor perimenopausal symptoms and treatment effects.

How similar studies have gone: Previous research using physiological wearables to detect vasomotor events and sleep disturbances has shown promising but variable results, and rigorous validation against daily self-report remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Females between 35-55 years of age, inclusive
2. Self-reported perimenopausal women experiencing hot flushes or night sweats
3. Individuals of child-bearing potential must confirm they are not pregnant, do not plan to become pregnant, and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include:

   * Double-barrier method
   * Intrauterine devices
   * Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s)
   * Vasectomy of partner at least 6 months prior to screening
   * Abstinence
4. Agrees to maintain current lifestyle as much as possible throughout the study, including diet, exercise, supplements/medications, and sleep
5. Provided voluntary and informed consent to participate in the study
6. Generally healthy as determined by medical history with no unstable diagnosed medical conditions

Exclusion Criteria:

1. Allergy or sensitivity to adhesive used for wearing the investigational device
2. Self-reported use of a pacemaker
3. Self-reported unstable diagnosed anxiety disorder
4. Self-reported sleep disorder requiring medical treatment
5. Self-reported skin conditions or sensitive skin around the area of application
6. Self-reported surgery in the past three months or individuals who have planned surgery during the course of the study
7. Alcohol intake average of ˃1 standard drink per day
8. Alcohol or drug abuse within the last 12 months that has required treatment
9. Current use of prescribed and/or over-the-counter (OTC) medications/supplements that may impact data recorded by the investigational device (see Section 7.3)
10. Participation in other clinical research studies 30 days prior to screening
11. Individuals who are unable to give informed consent
12. Any other condition or lifestyle factor, that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant

Where it's running

  • KGK Science Inc.
    London, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.